Frailty (medicine)

Frailty (medicine)
Name	Frailty
Field	Geriatrics
Synonyms	Frailty syndrome; Geriatric frailty
Symptoms	Decline in strength, endurance, physiologic reserve
Complications	Falls, disability, hospitalization, mortality
Onset	Gradual
Duration	Variable
Causes	Multisystem physiologic decline
Risks	Advanced age; comorbidities
Diagnosis	Clinical assessment; frailty indices; phenotype models
Differential	Disability; sarcopenia; malnutrition; cognitive impairment
Treatment	Multidomain interventions; exercise; nutrition; medication review
Prognosis	Increased morbidity and mortality

Frailty (medicine) is a clinical state characterized by decreased physiologic reserve and increased vulnerability to stressors, most commonly observed in older adults. It predicts adverse outcomes such as falls, hospitalization, dependence, and death across settings like primary care, acute hospitals, and long-term care facilities. Research on frailty spans geriatrics, internal medicine, public health, and health services, informing screening, prevention, and management strategies.

Definition and Epidemiology

Frailty is defined variably across frameworks including the phenotype model and cumulative deficit model, influencing prevalence estimates reported in population studies in countries such as United States, United Kingdom, Japan, France, and Australia. Prevalence increases with age and is higher in community-dwelling elders, outpatients, and residents of institutions like nursing homes and long-term care hospitals. Large cohort studies—such as those based in Framingham Heart Study, Health and Retirement Study, English Longitudinal Study of Ageing, and Rotterdam Study—report prevalence ranges from single digits in younger-old groups to >25% in those aged 85 and older. Socioeconomic factors linked to geographic regions like Sub-Saharan Africa, South Asia, and Eastern Europe modify incidence through comorbidity patterns and access to services provided by organizations such as World Health Organization and national agencies like Centers for Disease Control and Prevention.

Pathophysiology and Risk Factors

Frailty arises from multisystem physiologic dysregulation involving musculoskeletal, endocrine, immune, hematologic, and neurologic systems and is associated with processes studied in institutions like National Institutes of Health and laboratories at universities such as Harvard University and University of Oxford. Sarcopenia, chronic inflammation (elevated biomarkers identified in cohorts from Karolinska Institute), hormonal changes, oxidative stress, and mitochondrial dysfunction contribute to declining reserve. Risk factors include advanced age, multimorbidity (for example, diabetes mellitus, congestive heart failure, chronic obstructive pulmonary disease), polypharmacy often reviewed in settings like pharmacies and programs by National Health Service, malnutrition examined in studies from Food and Agriculture Organization, social determinants such as isolation addressed by United Nations reports, and acute insults such as hip fracture or sepsis.

Clinical Assessment and Diagnosis

Assessment strategies derive from models operationalized in research from centers like Johns Hopkins School of Medicine and McMaster University. The phenotype model (shrinking, weakness, exhaustion, slowness, low activity) operationalized by investigators at Wake Forest University contrasts with the cumulative deficit Frailty Index developed using data from cohorts including Canadian Study of Health and Aging. Common assessment tools used in clinics affiliated with institutions such as Mayo Clinic and Cleveland Clinic include gait speed tests, grip strength dynamometry, timed up-and-go, the Clinical Frailty Scale promoted in National Institute for Health and Care Excellence guidance, and electronic frailty indices embedded in health records at systems like Kaiser Permanente. Diagnostic evaluation incorporates comorbidity assessment, medication reconciliation often involving professional societies like American Geriatrics Society, nutritional screening, and cognitive testing such as instruments validated by Alzheimer's Association studies.

Management and Interventions

Management emphasizes multidomain interventions promoted in guidelines from bodies like World Health Organization and European Union health programs. Core elements include individualized exercise programs (resistance and balance training developed in trials at University of Sydney and University of British Columbia), protein and calorie optimization informed by nutrition research from Harvard T.H. Chan School of Public Health, deprescribing initiatives advocated by British Geriatrics Society, and comprehensive geriatric assessment models implemented in hospitals like Guy's and St Thomas' NHS Foundation Trust. Interventions also involve vaccination campaigns coordinated by Centers for Disease Control and Prevention to reduce infectious stressors, perioperative frailty pathways used in centers such as Johns Hopkins Hospital, and social support programs run by organizations like Age UK and AARP. Pharmacologic treatments target specific contributors (e.g., osteoporotic therapy per National Osteoporosis Foundation guidance) rather than frailty per se.

Outcomes and Prognosis

Frailty predicts a spectrum of adverse outcomes documented in registries and trials from institutions including National Surgical Quality Improvement Program and Registry of Older Patients. Outcomes include elevated rates of postoperative complications after procedures such as hip arthroplasty and coronary artery bypass grafting, increased length of hospital stay in systems like Medicare, higher readmission rates, escalating need for long-term care in facilities overseen by agencies like Centers for Medicare & Medicaid Services, and mortality. Prognostic instruments derived from cohort studies at University College London and University of Glasgow quantify risk to inform decision-making for interventions including dialysis initiation, cancer therapy, and transplantation evaluated at centers such as Memorial Sloan Kettering Cancer Center.

Special Populations and Settings

Frailty manifests differently in subgroups and contexts studied by specialist centers such as Veterans Health Administration and pediatric units in institutions like Great Ormond Street Hospital when considering rare early-onset syndromes. Specific settings include acute care wards, elective surgical pathways, rehabilitation units, and community programs coordinated with agencies like Community Care Network. Marginalized populations in regions such as Indigenous Australians communities and urban centers like Detroit experience distinct risk profiles shaped by social determinants addressed by organizations including Centers for Disease Control and Prevention and World Health Organization. Tailored approaches in transplant candidates at hospitals like Mayo Clinic and oncology patients managed at Dana-Farber Cancer Institute exemplify adaptation of frailty assessment and interventions to specialized clinical pathways.

Category:Geriatric medicine